GLAXF GSK PLC
- 22.115
- -0.135-0.61%
GSK PLC News
GSK Says Depemokimab Reduced Asthma Attacks in 2 Late-Stage Studies
GSK (GSK) said Tuesday that its depemokimab reduced asthma attacks in two phase 3 clinical trials that evaluated the efficacy and safety of the potential treatment compared with placebo in patients wi
GSK Potential Blockbuster Asthma Drug Shows Promise in Latest Trial -- Update
By Najat Kantouar and Helena Smolak GSK's experimental drug for asthma met its goals in the latest trial, moving a treatment with potential blockbuster sales of 3 billion pounds ($3.81 billion) annua
GSK's Asthma Drug Reduces Severe Attacks in Late-stage Studies
GSK (GSK.L) on Tuesday said its depemokimab drug met the main goals of two late-stage trials after it helped reduce severe asthma attacks in the adult and adolescent participants. The phase 3 clinical
GSK Faces Whistleblower Suit From Lab That Exposed Zantac Risk; Wisner, Moore To Represent Valisure In Case; Valisure Claims GSK Hid Drug Risks While U.S. Paid For Zantac
GSK Faces Whistleblower Suit From Lab That Exposed Zantac Risk; Wisner, Moore To Represent Valisure In Case; Valisure Claims GSK Hid Drug Risks While U.S. Paid For Zantac
GSK Plc Divests Entire Stake in Haleon PLC
Trending Tickers: Tesla, Reddit, Walmart and GSK
GSK to Sell Remaining Stake in Haleon Valued at Around $1.27 Billion -- Update
By David Sachs GSK said it will sell its remaining stake in Haleon, ending its gradual disposal of shares in the company formed by a joint venture with Pfizer in 2019. The British pharmaceutical com
GSK PLC: Shares Are Equivalent to Around 4.2% of Haleon's Share Capital
GSK PLC: Shares Are Equivalent to Around 4.2% of Haleon's Share Capital
GSK PLC Disposal Will Be Conducted Through a Placing to Institutional Investors
GSK PLC Disposal Will Be Conducted Through a Placing to Institutional Investors
GSK PLC: Price Will Be Set Via an Accelerated Bookbuild Offering
GSK PLC: Price Will Be Set Via an Accelerated Bookbuild Offering
GSK PLC: Intends to Sell Approximately 385 Mln Shrs in Haleon
GSK PLC: Intends to Sell Approximately 385 Mln Shrs in Haleon
GSK PLC's Dividend Analysis
GSK PLC To Go Ex-Dividend On May 16th, 2024 With 0.18872 USD Dividend Per Share
May 15th - $GSK PLC(GLAXF.US)$ is trading ex-dividend on May 16th, 2024. Shareholders of record on May 17th, 2024 will receive 0.18872 USD dividend per share on July 11th, 2024. The ex-dividend da
GSK Plc (LON:GSK) Stock Goes Ex-Dividend In Just Four Days
GSK (LON:GSK) Is Paying Out A Dividend Of £0.15
GSK Invests in BioVersys to Speed Development of Potential Tuberculosis Treatment
GSK (GSK) and BioVersys have expanded their collaboration to speed up development of alpibectir, a potential tuberculosis treatment, BioVersys said Tuesday. As part of the deal, GSK will take a 12.3 m
BioVersys And GSK Boost Fight Against Tuberculosis With Expanded Partnership And Series C Funding Increase By CHF 12.3M
Strategic collaboration with GSK expanded to accelerate clinical development of alpibectir for the treatment of tuberculosisGSK to participate in Series C Extension with equity investmentSeries C fina
GSK Plc (NYSE:GSK) Q1 2024 Earnings Call Transcript
Research Alert: CFRA Keeps Hold Opinion On Adss Of Gsk Plc
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We adjust our target price by USD5 to US
GSK PLC To Go Ex-Dividend On May 16th, 2024 With 0.18869 USD Dividend Per Share
May 2nd - $GSK PLC(GLAXF.US)$ is trading ex-dividend on May 16th, 2024. Shareholders of record on May 17th, 2024 will receive 0.188 USD dividend per share on July 11th, 2024. The ex-dividend date
Analysis
Price Target
No Data
